WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $26.13, but opened at $24.80. WuXi AppTec shares last traded at $24.0250, with a volume of 523 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to MarketBeat.com, WuXi AppTec presently has a consensus rating of “Strong Buy”.
View Our Latest Report on WUXAY
WuXi AppTec Stock Down 6.1%
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
See Also
- Five stocks we like better than WuXi AppTec
- AST SpaceMobile Is Down 54%—Can FCC Progress and BlueBirds Reverse the Slide?
- Don’t Miss These 3 Companies Delivering Strong Guidance Updates
- Insider Confidence Is Building in These 3 Very Different Stocks
- The SaaSpocalypse Trade Is Cracking, and These 5 Stocks Are Leading Higher
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
